NVAX Jan 2025 3.500 call
| Previous Close | 11.24 |
| Open | 11.24 |
| Bid | 15.80 |
| Ask | 16.45 |
| Strike | 3.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 11.24 - 11.24 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 43 |
Yahoo FinanceNovavax's stock surges almost 300% in the past month
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
- Yahoo Finance Video
Novavax stock rises on COVID vaccine delivery projections
Shares of Novavax (NVAX) are surging after the company announced it will meet delivery expectations for the fall COVID vaccine push. All COVID vaccines will use the JN.1 strain, part of the Omicron subvariant family. The FDA also set a final date for fully approving the company's COVID vaccine beyond its emergency use authorization. Anjalee Khemlani joins the Morning Brief to break down the details. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This article was written by Gabriel Roy
Investor's Business DailyNovavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Novavax stock zipped higher and then plunged Thursday after the FDA set a potential approval date for its Covid vaccine in April.
